Principle Partnership Programme 2021
The British Cardiovascular Society values strong collaboration with industry and is grateful for the all the support this enables for the delivery of the annual conference and our wider educational agenda. This benefits practising cardiologists and patients.
In 2021, the BCS has worked with a number of key organisations as Principal Partners. These Programmes are a framework for engagement and dialogue between the BCS and industry focused on achieving strategic goals in a transparent way within agreed a robust governance framework.
The partnerships provide a core agreement as well as bespoke opportunities for joint working.They are offered on a one year basis but with the intention of developing rolling multi-year arrangements.
The BCS is delighted to confirm Partnerships with the following organisations in 2021:
Bayer | Daiichi- Sankyo | Medtronic | Novartis | Novo Nordisk